Clinical spectrum of melioidosis at a tertiary care hospital in South India  by Malladi, S.V.S. et al.
470 17th International Congress on Infectious Diseases / International Journal of Infectious Diseases 45S (2016) 1–477
Conclusion: The present case gives dimension to varied presen-
tations of brucellosis. In particular brucellosis should be kept as a
strong differential diagnosis of PUO in a endemic zone despite non
encouraging brucella serology results . We advocate serial serol-
ogy testing should be performed before contemplating invasive
procedures for establishing cause for PUO.
http://dx.doi.org/10.1016/j.ijid.2016.02.993
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Background:Melioidosis, causedby theGram-negativebacillus
Burkholderia pseudomallei, is an infectious disease of public health
and a biothreat importance. Clinical presentations of melioidosis
are protean, hence, called a remarkable imitator. The number of
casesofmelioidosis reported in India is considered tobe the tipof an
iceberg as several casesmay not be diagnosed due to lack of aware-
ness among the clinicians about the infection and the laboratories
not capable of isolating and identifying B.pseudomallei.
Methods & Materials: It is a retrospective study and data was
collected fromthe inpatient case records of patientswithmelioido-
sis from 2004 to 2014. We report the clinical features and outcome
of cases of this unusual infection at our institute, a tertiary care
hospital in South India.
Results: There were 17 cases of melioidosis from our Institute
over last 10 years. Majority of the patients were agriculturists by
occupation. Diabetes mellitus was the underlying comorbid con-
dition in all patients except in one case. Twelve out of 17 cases
(70.59%)presented with sepsis. Six cases (35.29%) had fulminant
course and succumbed before the microbiology reports arrived
and deﬁnitive treatment is started. Skin lesions were apparent
in 10/17(58.82%) cases. Seven out of 17(41.18%) cases had deep-
seated abscesses involving the liver, spleen, prostate, brain, bones
and joints. Thirteen cases out of 17(76.47%) had pneumonia.
In all the cases, B. pseudomallei was isolated from the blood
using the BacT/alert (bioMerieux) system, within 24 hours. All
the isolates were sensitive to co-amoxiclav, co-trimoxazaole,
ceftazidime and carbapenems. The distinctive pattern of suscep-
tibility, to TMP-SMX was an important clue in the identiﬁcation of
B.pseudomallei.
Elevenpatientsoutof 17 receivedappropriate antibiotic therapy
based on the susceptibility reports, by 4th day of hospitalization.
The initial intensive regime consisted of intravenous ceftazidime
for 2 weeks or imipenem or meropenem for 14 days followed by
oral TMP-SMX (320/1600 mg/kg 12th hourly) for 3-6 months.
Chest radiograph showing left upper lobe inﬁltrates in a case
of melioidosis
Conclusion: Pneumonia was the most common presentation of
infection by B.psuedomallei. Diabetes is present in 94% of cases of
melioidosis presenting to our institute. Mortality was observed in
6 (35.29%) cases.
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